Company Analysis
Sign in

Quantum Biopharma Ltd. (QNTM)

Nasdaq: QNTM · Pharmaceutical Preparations · Toronto · filing with the SEC since 2019
Full chart Alerts Compare
Grade4.4
◀ Past 5.8● Present 4.1▶ Future 3.9
7 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Income statement, as filed

In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019
Report filedMar 26, 2026Mar 28, 2025Apr 2, 2024Mar 31, 2023Mar 31, 2022Mar 17, 2021Mar 4, 2020
For lenders
Net interest income236,084572,891r786,363367,7351,2923,691·
Research and development2,763,1746,083,3783,859,1786,910,8446,328,1047,832,8470
Selling, general and administrative9,047,9189,410,0979,032,724····
Sales and marketing···616,002···
General and administrative·9,410,0979,032,72414,450,09415,926,10310,058,0838,407,427
Total operating expenses15,302,37416,136,26023,789,49827,429,61133,743,660··
Operating income-15,302,374-16,136,260-23,789,498-27,429,611-33,743,660-30,691,088-22,484,293
Finance costs158,06333,01729948,82269,404235,581155,316
Interest income··568,919183,037···
Income from continuing operations-26,956,840-14,915,529-18,230,588-26,703,662-33,937,956-28,452,232-34,080,963
Income from discontinued operations·003,096,834-1,347,473-3,347,561-5,048,557
Net income···-23,606,828-35,285,429-31,799,793-39,129,520
Net income to non-controlling interests-26,956,840-14,915,529-18,230,588-23,606,828-35,285,429··
Weighted average shares, basic···595,883b537,619b185,292b·
Weighted average shares, diluted·1,136,9221rb595,883r537,619b185,292b108,558b
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-65 reverse split.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Net interest income interest earned less interest paidifrs-full:InterestRevenueExpense
Research and development spent on inventing what it sells nextifrs-full:ResearchAndDevelopmentExpense
Selling, general and administrative the cost of selling and of running the companyifrs-full:SellingGeneralAndAdministrativeExpense
Sales and marketing the cost of finding and serving customersifrs-full:SellingExpense
General and administrative the cost of running the company itselfifrs-full:GeneralAndAdministrativeExpense
Total operating expenses the running costs togetherifrs-full:OperatingExpense
Operating income profit from running the business, before interest and taxifrs-full:ProfitLossFromOperatingActivities
Finance costs what its borrowing costifrs-full:FinanceCosts
Interest income what its cash and investments earnedifrs-full:RevenueFromInterest
Income from continuing operations profit from the businesses it keepsifrs-full:ProfitLossFromContinuingOperations
Income from discontinued operations profit or loss from businesses it sold or closedifrs-full:ProfitLossFromDiscontinuedOperations
Net income the whole group's profit, minority holders' share includedifrs-full:ProfitLoss
Net income to non-controlling interests the share that belongs to minority holdersifrs-full:ProfitLossAttributableToNoncontrollingInterests
Weighted average shares, basic the average count of shares outstandingifrs-full:WeightedAverageShares
Weighted average shares, diluted the average count with every share that could be issuedifrs-full:AdjustedWeightedAverageShares
SI Assistanton QNTM · research, not advice